CardioPharmaGENET Presented at the ISABS & Mayo Clinic Conference in Dubrovnik
CardioPharmaGENET was presented at the 14th ISABS & Mayo Clinic Conference: Advances in Application of Artificial Intelligence in Precision Medicine, held in Dubrovnik, Croatia. The conference brought together leading experts from academia, healthcare, and industry to discuss the latest developments in precision medicine, artificial intelligence, and genomics.
During the conference, the Chair of the CardioPharmaGENET, Dr. Adna Ašić, introduced the project’s vision and objectives, highlighting its multidisciplinary approach to advancing personalized cardiovascular medicine. The presentation showcased how pharmacogenomics and integrated risk assessment can support not only individualized therapy selection and dosing but also improve disease risk prediction, identify potential comorbidities, and contribute to the prediction of adverse cardiovascular outcomes, including sudden cardiac death.
The conference also provided an excellent opportunity to promote the Action among researchers and clinicians working in precision medicine. Discussions continued throughout the event during scientific sessions, panel discussions, and networking activities, fostering new connections and increasing the visibility of CardioPharmaGENET within the international research community. Participation in the ISABS & Mayo Clinic Conference represents another important step in expanding the reach of the Action, strengthening collaborations, and promoting innovative approaches that will contribute to the future of precision cardiovascular medicine.
